Functional identification of organic cation transporter 1 as an atenolol transporter sensitive to flavonoids

Biochemistry and Biophysics Reports

Volumn 2, Issue , 2015, Pages 166-171

  Mimura, Yoshihisa ^a   Yasujima, Tomoya ^a   Ohta, Kinya ^a   Inoue, Katsuhisa ^b   Yuasa, Hiroaki ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Absorption; Apple juice; Atenolol; Food drug interaction; Intestine; OCT1

Indexed keywords

ATENOLOL TRANSPORTER; CARRIER PROTEIN; FLAVONOID; ORGANIC CATION TRANSPORTER 1; PHLORETIN; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APPLE JUICE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; DOG; DRUG TRANSPORT; FLOW RATE; FOOD DRUG INTERACTION; INTESTINE ABSORPTION; INTESTINE CELL; MDCK CELL LINE; MICHAELIS CONSTANT; MICHAELIS MENTEN KINETICS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SENSITIVITY ANALYSIS;

EID: 84937042459     PISSN: None     EISSN: 24055808     Source Type: Journal    
DOI: 10.1016/j.bbrep.2015.06.005     Document Type: Article

References (32)

1. Hansson L., Aberg H., Karlberg B.E., et al. Controlled study of atenolol in treatment of hypertension. Br. Med. J. 1975, 17:367-370.
2. Bachmann M., Raeber E., Burckhardt D., et al. Atenolol in the treatment of angina pectoris. Schweiz Med. Wochenschr. 1979, 109:1857-1860.
3. Robinson C., Birkhead J., Crook B., et al. Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent. Br. Heart J. 1978, 40:14-21.
4. Kirch W., Görg K.G. Clinical pharmacokinetics of atenolol--a review. Eur. J. Drug Metab. Pharmacokinet. 1982, 7:81-91.
5. Lennernäs H., Ahrenstedt O., Ungell A.L. Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. Br. J. Clin. Pharmacol. 1994, 37:589-596.
6. Jeon H., Jang I.J., Lee S., et al. Apple juice greatly reduces systemic exposure to atenolol. Br. J. Clin. Pharmacol. 2013, 75:172-179.
7. Lilja J.J., Raaska K., Neuvonen P.J. Effects of orange juice on the pharmacokinetics of atenolol. Eur. J. Clin. Pharmacol. 2005, 61:337-340.
8. Reeves P.R., McAinsh J., McIntosh D.A., et al. Metabolism of atenolol in man. Xenobiotica 1978, 8:313-320.
9. Kalliokoski A., Niemi M. Impact of OATP transporters on pharmacokinetics. Br. J. Pharmacol. 2009, 158:693-705.
10. Dresser G.K., Bailey D.G., Leake B.F., et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin. Pharmacol. Ther. 2002, 71:11-20.
11. Rebello S., Zhao S., Hariry S., et al. Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. Eur. J. Clin. Pharmacol. 2012, 68:697-708.
12. Shirasaka Y., Kuraoka E., Spahn-Langguth H., et al. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J. Pharmacol. Exp. Ther. 2010, 322:181-189.
13. Ieiri I., Doi Y., Maeda K., et al. Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose. J. Clin. Pharmacol. 2012, 52:1078-1089.
14. Gorboulev V., Ulzheimer J.C., Akhoundova A., et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 1997, 16:871-881.
15. Zhang L., Dresser M.J., Gray A.T., et al. Cloning and functional expression of a human liver organic cation transporter. Mol. Pharmacol. 1997, 51:913-921.
16. Wang D.S., Jonker J.W., Kato Y., et al. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J. Pharmacol. Exp. Ther. 2002, 302:510-515.
17. Yasujima T., Ohta K.Y., Inoue K., et al. Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins. Drug Metab. Dispos. 2010, 38:715-721.
18. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 2007, 24:1227-1251.
19. Tamai I. Oral drug delivery utilizing intestinal OATP transporters. Adv. Drug Deliv. Rev. 2012, 64:508-514.
20. Han T.K., Everett R.S., Proctor W.R., et al. Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes. Mol Pharmacol 2013, 84:182-189.
21. Martinez V., Maguregui M.I., Jiénez R.M., et al. Determination of the pKa values of beta-blockers by automated potentiometric titrations. J. Pharm. Biomed. Anal. 2000, 23:459-468.
22. Shirasaka Y., Shichiri M., Mori T., et al. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J. Pharm. Sci. 2013, 102:3418-3426.
23. Mandery K., Balk B., Bujok K., et al. Inhibition of hepatic uptake transporters by flavonoids. Eur. J. Pharm. Sci. 2012, 46:79-85.
24. Yasujima T., Ohta K., Inoue K., et al. Characterization of human OCT1-mediated transport of DAPI as a fluorescent probe substrate. J. Pharm. Sci. 2011, 100:4006-4012.
25. Gao J., Sanchez-Medina A., Pendry B.A., et al. Validation of a HPLC method for flavonoid biomarkers in skullcap (Scutellaria) and its use to illustrate wide variability in the quality of commercial tinctures. J. Pharm. Pharm. Sci. 2008, 11:77-87.
26. Han T.K., Proctor W.R., Costales C.L., et al. Four cation-selective transporters contribute to apical uptake and accumulation of metformin in caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 2015, 352:519-528.
27. Jonker J.W., Wagenaar E., Mol C.A., et al. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Mol. Cell Biol. 2001, 21:471-477.
28. Dolton M.J., Roufogalis B.D., McLachlan A.J. Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides. Clin. Pharmacol. Ther. 2012, 92:622-630.
29. Bailey D.G. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br. J. Clin. Pharmacol. 2010, 70:645-655.
30. Amee B., Weintraub R.A. Drug interactions with grapefruit juice. Clin. Pharmacokinet 1997, 33:103-121.
31. Guo L.Q., Fukuda K., Ohta T., et al. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab. Dispos. 2000, 28:766-771.
32. Schieber A., Keller P., Carle R. Determination of phenolic acids and flavonoids of apple and pear by high-performance liquid chromatography. J. Chromatogr. A 2001, 910:265-273.